英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Ozagrel Impurity 44 |
尿酸雜質(zhì)1 |
2124-54-1 |
詳細(xì)
|
Dacarbazine Impurity 5 |
丹曲林-13C3 |
1185234-99-4 |
詳細(xì)
|
Tiletamine-d5 Hydrochloride |
|
70746-06-4 |
詳細(xì)
|
Tiletamine HCl |
6-Hydroxy Debrisoquin |
61911-79-3 |
詳細(xì)
|
Deferiprone |
(R)-XANTHOANTHRAFIL |
247568-68-9 |
詳細(xì)
|
Debrisoquine Hemisulfate-13C |
去鐵酮 |
30652-11-0 |
詳細(xì)
|
Xanthone Impurity 5 |
Β-鵝膏毒肽 |
21150-22-1 |
詳細(xì)
|
Xanthoanthrafil-d3 |
N-(芐氧基)氨基甲酸叔丁酯 |
79722-21-7 |
詳細(xì)
|
Xanthine |
2,6-二氟苯磺酰氯 |
60230-36-6 |
詳細(xì)
|
Dabrafenib Impurity 7 |
異硫藍(lán) |
68238-36-8 |
詳細(xì)
|
Dacarbazine-d6 |
旦著能 |
7261-97-4 |
詳細(xì)
|
Xanthone Impurity 4 |
|
1065274-12-5 |
詳細(xì)
|
Dabrafenib Impurity 6 |
4-甲基肉桂酸甲酯 |
88738-86-7 |
詳細(xì)
|
Dasabuvir |
8-Hydroxy Debrisoquin |
46286-45-7 |
詳細(xì)
|
Xanthoanthrafil |
(5-氨基戊基)(苯基甲氧基)氨基甲酸叔丁酯 |
129245-21-2 |
詳細(xì)
|
Xanthoanthrafil Impurity 1 |
N-(4-氰基丁基)-N-(苯基甲氧基)氨基甲酸叔丁酯 |
128173-50-2 |
詳細(xì)
|
Darolutamide Impurity 4 |
5-Hydroxy Debrisoquin |
70746-05-3 |
詳細(xì)
|
Debrisoquine Impurity 5 |
rac Xanthoanthrafil-d3 |
1216710-83-6 |
詳細(xì)
|
Dantrolene Impurity 4 |
5-hydroxy-1-[(E)-[5-(2,3,5,6-tetradeuterio-4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione |
1217225-15-4 |
詳細(xì)
|
Dantrolene-13C3 |
5-(4-CHLORO-3-FLUOROPHENYL)-2-FUROIC ACID |
893734-58-2 |
詳細(xì)
|
Etravirine Impurity 13 |
13C2,2H6]-達(dá)拉非尼羧酸二鋰鹽 |
1195873-54-1 |
詳細(xì)
|
Dantrolene Impurity 1 (Dantrolene USP RC A) |
5-(3-CHLORO-PHENYL)-FURAN-2-CARBOXYLIC ACID |
41019-44-7 |
詳細(xì)
|
*Carbon tetrabromide |
p-NCS-Bz-DFO |
1222468-90-7 |
詳細(xì)
|
Evogliptin Tartrate |
3-溴-2-氟苯甲酸 |
161957-56-8 |
詳細(xì)
|
Deferoxamine Impurity 8 |
|
1119156-37-4 |
詳細(xì)
|
Xanthone Impurity 1 (Xanthone Triflate) |
|
1119156-19-2 |
詳細(xì)
|
Dalfopristin |
丹曲林鈉 |
14663-23-1 |
詳細(xì)
|
Etravirine Impurity 10 |
Xanthine-13C15N2 |
1262670-81-4 |
詳細(xì)
|
Uric Acid Impurity 1 |
5-對(duì)硝基苯基糠醛 |
7147-77-5 |
詳細(xì)
|
Dantrolene Impurity 5 |
N-{[5-(4-NITROPHENYL)FURAN-2-YL]METHYLIDENE}HYDROXYLAMINE |
19934-32-8 |
詳細(xì)
|
Dabrafenib Impurity 8 |
Indomethacin Impurity 2 |
72155-33-0 |
詳細(xì)
|
Regorafenib Impurity 82 |
達(dá)福普汀 |
112362-50-2 |
詳細(xì)
|
Deferoxamine Impurity 4 |
占噸酮 |
90-47-1 |
詳細(xì)
|
Dantrolene Impurity 8 |
ORM-15341 |
1297537-33-7 |
詳細(xì)
|
Dantrolene Impurity 9 |
2-氯-4-(1H-吡唑-3-基)苯甲腈 |
1297537-37-1 |
詳細(xì)
|
Deferoxamine Impurity 3 |
XANTHOFULVIN |
151466-15-8 |
詳細(xì)
|
Dantrolene Impurity 11 (5-Hydroxy Dantrolene) |
達(dá)洛魯胺雜質(zhì)4 |
2407645-49-0 |
詳細(xì)
|
Xanthone Impurity 9 |
|
97372-51-5 |
詳細(xì)
|
3-Chloro-2-propen-1-ol (E/Z Mixture) |
丹曲林鈉雜質(zhì) |
14663-28-6 |
詳細(xì)
|
Indomethacin Impurity 19 |
(2R,3S)-2-羥甲基-2,3-二氫呋喃-3-醇 |
96761-00-1 |
詳細(xì)
|
Xanthone Impurity 8 |
(R)-5-(1,5-二甲基-4-己烯基)-鄰甲酚 |
30199-26-9 |
詳細(xì)
|
Dantrolene Impurity 3 (Dantrolene USP RC C) |
5-羥基丹曲洛林 |
52130-25-3 |
詳細(xì)
|
Dasabuvir Impurity 2 |
8-O-Benzyl Debrisoquin Sulfate |
1346604-07-6 |
詳細(xì)
|
Dantrolene |
1-AMino-5-hydroxyhydantonin |
42839-65-6 |
詳細(xì)
|
Dantrolene Impurity 6 |
達(dá)洛魯胺 |
1297538-32-9 |
詳細(xì)
|
Etravirine Impurity 12 |
達(dá)帕菲尼雜質(zhì) |
1423119-98-5 |
詳細(xì)
|
Deferiprone Impurity 3 |
去鐵銨 |
138-14-7 |
詳細(xì)
|
Etravirine Impurity 14 |
去甲基達(dá)拉非尼 |
1195765-47-9 |
詳細(xì)
|
Deferoxamine Impurity 9 |
|
1119156-33-0 |
詳細(xì)
|
Xanthone Impurity 2 (Atroviridin) |
|
104553-84-6 |
詳細(xì)
|
Darolutamide Impurity 2 |
Debrisoquin-13C,15N2 Hemisulfate |
1246814-89-0 |
詳細(xì)
|
Deferiprone-d3 |
(R)-SLV 319 |
656827-86-0 |
詳細(xì)
|
beta-Amatoxin |
羅替戈汀雜質(zhì)21 |
101470-23-9 |
詳細(xì)
|
Dabrafenib Impurity 9 |
3-氟-4-硝基苯酚 |
394-41-2 |
詳細(xì)
|
Deferoxamine Impurity 7 |
5-bromo-3,4-dimethyl-9H-xanthen-9-one |
1035912-43-6 |
詳細(xì)
|
Decitabine Impurity 30 |
丹曲林鈉雜質(zhì) |
55227-60-6 |
詳細(xì)
|
Xanthone Impurity 10 |
5-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-methyl-3-cyclohexene-1,1-diol |
915301-61-0 |
詳細(xì)
|
Xanthone Impurity 12 |
4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-cyclohexen-1-one |
196193-23-4 |
詳細(xì)
|
Dantrolene Impurity 2 (Dantrolene USP RC B) |
5-(3,4-二氯苯基)-2-糠酸 |
54023-01-7 |
詳細(xì)
|
Dabrafenib-d9 |
布瓦西坦雜質(zhì)81 |
774198-33-3 |
詳細(xì)
|
Xanthofulvin |
|
1119156-28-3 |
詳細(xì)
|
Etravirine Impurity 11 |
XANTHINE AMINE CONGENER;XAC |
96865-92-8 |
詳細(xì)
|
Darolutamide Impurity 3 |
rac 4-Hydroxydebrisoquine Hemisulfate |
62580-84-1 |
詳細(xì)
|
Xanthine-13C-15N2 |
2,2,2-三甲基硫代乙酰胺 |
630-22-8 |
詳細(xì)
|
Debrisoquine Impurity 1 |
Deferiprone-d3 |
1346601-82-8 |
詳細(xì)
|
Debrisoquine Impurity 6 |
N-(3,4-DiMethoxybenzyl)-2-fluoro-5-nitrobenzaMide |
247568-67-8 |
詳細(xì)
|
Darolutamide |
達(dá)塞布韋 |
1132935-63-7 |
詳細(xì)
|
Debrisoquine Impurity 3 |
1-甲基-3-(甲基胺)吡咯烷-2-酮 |
1248282-93-0 |
詳細(xì)
|
Xanthone Impurity 6 |
3-(4-嗎啉)-1-丙醇 |
4441-30-9 |
詳細(xì)
|
Ibipinabant Impurity 2 |
N-(苯基甲氧基)-1,5-戊二胺 |
160388-21-6 |
詳細(xì)
|
Uric Acid-13C-15N2 |
丹曲林雜質(zhì)B |
57268-33-4 |
詳細(xì)
|
Darolutamide-d6 |
1-(3-叔丁基-5-碘-4-甲氧基苯基)嘧啶-2,4(1H,3H)-二酮 |
1132940-53-4 |
詳細(xì)
|
Debrisoquine Impurity 2 |
3-羥基-2-甲基-4(1H)-吡啶酮 |
17184-19-9 |
詳細(xì)
|
Etravirine Impurity 15 |
羥基達(dá)拉非尼 |
1195767-77-1 |
詳細(xì)
|
Deferoxamine Impurity 2 |
氯前列醇雜質(zhì)5 (DL-氯前列醇鈉鹽) |
55028-72-3 |
詳細(xì)
|
Cloprostenol Impurity 5 (DL-Cloprostenol Sodium Salt) |
|
1119156-42-1 |
詳細(xì)
|
Xanthone Impurity 3 |
|
1119363-28-8 |
詳細(xì)
|
Dabrafenib Impurity 4 |
對(duì)甲基肉桂酸甲酯 |
20754-20-5 |
詳細(xì)
|
Dantrolene Impurity 7 |
|
2484757-33-5 |
詳細(xì)
|
Xanthone |
|
1119156-22-7 |
詳細(xì)
|
Dantrolene Impurity 12 |
Tiletamine-d5 Hydrochloride |
1246818-12-1 |
詳細(xì)
|
Dapagliflozin Impurity 8 Propanediol Monohydrate |
|
247567-47-1 |
詳細(xì)
|
Uric Acid |
丹曲林雜質(zhì)A |
301359-05-7 |
詳細(xì)
|
Xanthine Impurity 1 |
達(dá)拉非尼雜質(zhì)1 |
1195768-20-7 |
詳細(xì)
|
Dabrafenib Impurity 5 |
2-甲基肉桂酸 |
2373-76-4 |
詳細(xì)
|
Xanthone Impurity 7 |
葉黃素 |
127-40-2 |
詳細(xì)
|
Ozagrel Impurity 43 |
尿酸 |
69-93-2 |
詳細(xì)
|
Deferoxamine Impurity 5 |
三羥甲基蒽醌 |
1445772-45-1 |
詳細(xì)
|
Xanthoanthrafil Impurity 3 |
9,12-Dioxo-21-phenyl-8-(phenylmethoxy)-20-oxa-2,8,13,19-tetraazaheneicosanoic Acid 1,1-Dimethylethyl Ester |
160388-22-7 |
詳細(xì)
|
Darolutamide Impurity 1 |
硫酸異喹胍 |
581-88-4 |
詳細(xì)
|
Xanthone Impurity 11 |
4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-6-hydroxy-2-cycloehexen-1-one |
915235-16-4 |
詳細(xì)
|
Deferoxamine Mesylate |
[5-[(Phenylmethoxy)amino]pentyl]-carbamic Acid 1,1-Dimethylethyl Ester |
153492-09-2 |
詳細(xì)
|
Moxifloxacin Impurity 130 |
達(dá)卡巴嗪相關(guān)物質(zhì)B |
63907-29-9 |
詳細(xì)
|
Dantrolene Impurity 10 |
達(dá)洛魯胺雜質(zhì)3 |
2415967-06-3 |
詳細(xì)
|
Xanthoanthrafil Impurity 2 |
4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid |
153492-12-7 |
詳細(xì)
|
Deferoxamine Impurity 6 |
Atroviridin |
207984-34-7 |
詳細(xì)
|
Isosulfan Blue |
3-chloroallyl alcohol |
29560-84-7 |
詳細(xì)
|
Dabrafenib Impurity 3 |
MOXIFLOXACIN RELATED COMPOUND F |
1179992-99-4 |
詳細(xì)
|
Brivaracetam Impurity 81 |
達(dá)卡巴嗪-D6 |
1185241-28-4 |
詳細(xì)
|
Debrisoquine Impurity 4 |
苯酰胺那非 |
1020251-53-9 |
詳細(xì)
|